;or its pharmaceutically acceptable salt wherein R1 means hydrogen atom (H), CH3 or CH2OH; R2 means CH3, CH2CH3; R3 means hydrogen atom (H), (C1-C6)-alkyl, hydroxylated (C1-C6)-alkyl, halogen atom; R4 means hydrogen atom (H), (C1-C6)-alkyl, hydroxylated (C1-C6)-alkyl or halogen atom; R5 means hydrogen atom (H) or halogen atom; R6 and R7 are similar or different and mean hydrogen atom (H), (C1-C6)-alkyl, hydroxylated (C1-C6)-alkyl or (C1-C6)-alkoxy-substituted (C1-C6)-alkyl; X represents NH or oxygen atom (O). These compounds inhibit exogenously or endogenously stimulated secretion of gastric acid and, therefore, can be used for prophylaxis and treatment of gastrointestinal inflammatory diseases. Invention describes also methods for their preparing, intermediates compounds, pharmaceutical preparations based on thereof, methods for inhibition of secretion of gastric acid, treatment of gastrointestinal inflammatory diseases and treatments of states associated with Helicobacter pylori infection.;EFFECT: improved preparing method, valuable medicinal properties of compounds.;26 cl, 49 ex"/>
机译:咪唑并吡啶衍生物,其制备和中间体化合物的方法,基于其的药物制备(各种),抑制胃酸分泌的方法,治疗胃肠道感染性肠炎的疾病和治疗方法
公开/公告号RU2238271C2
专利类型
公开/公告日2004-10-20
原文格式PDF
申请/专利权人
申请/专利号RU20000127019
申请日1999-04-23
分类号C07D471/04;A61K31/435;A61P1/04;
国家 RU
入库时间 2022-08-21 22:44:53